93
Participants
Start Date
July 9, 2020
Primary Completion Date
July 22, 2022
Study Completion Date
December 31, 2025
Ponatinib 30mg OD
Ponatinib 30mg OD
Ponatinib 45mg OD
Ponatinib 45mg OD
Anhui Provincial Hospital, Hefei
The First Affiliated Hospital of Anhui Medical University, Hefei
Nanfang Hospital of Southern Medical University, Guangzhou
Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Xiangya Hospital Central South University, Changsha
The First Affiliated Hospital of Soochow University, Suzhou
Shengjing Hospital of China Medical University, Shenyang
Qilu Hospital of Shandong University, Jinan
Second hospital of Shanxi Medical University, Taiyuan
Shenzhen Second People's Hospital, Shenzhen
West China Hospital, Sichuan University, Chengdu
The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou
1st affiliated hospital, Peking University, Beijing
Hematology Hospital, Chinese Academy of Medical Sciences, Tianjin
Lead Sponsor
Otsuka Beijing Research Institute
INDUSTRY